These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16147646)

  • 1. The treatment of severe hypertension in pregnancy: a review of current practice and knowledge in West-Midlands maternity units.
    Heazell AE; Mahomoud S; Pirie AM
    J Obstet Gynaecol; 2004 Nov; 24(8):897-8. PubMed ID: 16147646
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
    Sridharan K; Sequeira RP
    Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive Emergencies in Pregnancy.
    Olson-Chen C; Seligman NS
    Crit Care Clin; 2016 Jan; 32(1):29-41. PubMed ID: 26600442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral nifedipine or intravenous labetalol for severe hypertension?
    Magee LA
    BJOG; 2016 Jan; 123(1):48. PubMed ID: 26119227
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
    Chera-Aree P; Tengtrakulcharoen P; Leetheeragul J; Sampaojarean U; Surasereewong S; Wataganara T
    J Clin Pharmacol; 2020 Dec; 60(12):1662-1670. PubMed ID: 32598488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
    Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
    BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis.
    Shekhar S; Gupta N; Kirubakaran R; Pareek P
    BJOG; 2016 Jan; 123(1):40-7. PubMed ID: 26113232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy.
    Clark SM; Dunn HE; Hankins GD
    Semin Perinatol; 2015 Nov; 39(7):548-55. PubMed ID: 26344738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Gaynor MF; Wright GC; Vondracek S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial.
    Shekhar S; Sharma C; Thakur S; Verma S
    Obstet Gynecol; 2013 Nov; 122(5):1057-1063. PubMed ID: 24104790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
    Kilpatrick SJ; Abreo A; Greene N; Melsop K; Peterson N; Shields LE; Main EK
    Am J Obstet Gynecol; 2016 Jul; 215(1):91.e1-7. PubMed ID: 26829504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal antihypertensive drugs may influence cerebral oxygen extraction in preterm infants during the first days after birth.
    Verhagen EA; Kooi EM; van den Berg PP; Bos AF
    J Matern Fetal Neonatal Med; 2013 Jun; 26(9):871-6. PubMed ID: 23330812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial.
    Zulfeen M; Tatapudi R; Sowjanya R
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():46-52. PubMed ID: 30878897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of severe hypertension.
    Magee LA; von Dadelszen P
    Semin Perinatol; 2009 Jun; 33(3):138-42. PubMed ID: 19464503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
    Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents].
    Walss Rodriguez RJ; Flores Padilla LM
    Ginecol Obstet Mex; 1993 Mar; 61():76-9. PubMed ID: 8454221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To study the changes in maternal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension.
    Thakur M; Gainder S; Saha SC; Prakash M
    Pregnancy Hypertens; 2020 Jul; 21():180-183. PubMed ID: 32570152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral nifedipine versus intravenous labetalol for the treatment of severe hypertension in pregnancy.
    Shi Q; Leng W; Yao Q; Mi C; Xing A
    Int J Cardiol; 2015 Jan; 178():162-4. PubMed ID: 25464243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.